Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
43.50
+0.15 (+0.35%)
Official Closing Price
Updated: 4:10 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran
April 28, 2021
Sanofi SA (NASDAQ: SNY) stock climbed after its Q1 earnings beat earnings expectations and stuck to its full-year guidance, as well as reported progress on its...
Via
Benzinga
Topics
Earnings
Exposures
Financial
GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook
April 28, 2021
GlaxoSmithKline Plc Q1 revenue fell 18% in the first quarter, as the COVID-19 vaccination program delayed sales of its Shingrix shot for shingles.
Via
Talk Markets
Exposures
COVID-19
GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook
April 28, 2021
GlaxoSmithKline Plc (NYSE: GSK) Q1 revenue fell 18% in the first quarter, as the COVID-19 vaccination program delayed sales of its Shingrix shot for shingles....
Via
Benzinga
Exposures
COVID-19
US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses
April 27, 2021
The United States will start to share up to 60 million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine doses with other countries as they become...
Via
Benzinga
Exposures
COVID-19
Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine
April 26, 2021
As the demand for mRNA-based COVID-19 vaccines persists, Sanofi SA (NASDAQ: SNY) has entered an agreement with Moderna Inc (NASDAQ: MRNA)...
Via
Benzinga
Exposures
COVID-19
Analyzing The Price Action In GlaxoSmithKline Stock Today
April 15, 2021
GlaxoSmithKline's Stock Price And Volume Action GlaxoSmithKline (NYSE:GSK...
Via
Benzinga
Friday Market Report
April 23, 2021
Schlumberger Ltd of Curação today reported on its Q1 results which were good.
Via
Talk Markets
Oscar Telecast Sells Out Advertising Slots Despite Historically Low Award Show Ratings
April 23, 2021
ABC has sold out the available advertising slots for Sunday’s Academy Awards telecast, even though ratings on entertainment awards shows have been plummeting and this...
Via
Benzinga
1 Cheap Pharmaceutical Stock to Buy in 2021
April 23, 2021
GlaxoSmithKline presents a great opportunity for investors this year.
Via
The Motley Fool
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
GlaxoSmithKline's Immunotherapy For Endometrial Cancer Wins FDA Approval
April 22, 2021
The FDA has granted accelerated approval to GlaxoSmithKline plc's (NYSE: GSK) Jemperli (dostarlimab) for endometrial cancer. The approval covers...
Via
Benzinga
Exposures
Product Safety
Robots
April 19, 2021
Teva is suffering from fear of the legal risks of its opioid misselling which is overriding good news of its newer drugs.
Via
Talk Markets
Benzinga's Bulls And Bears Of The Week: Alphabet, Coinbase, GE, Quantumscape, Tesla And More
April 17, 2021
Benzinga has examined the prospects for many investor favorite stocks
Via
Benzinga
Happy News Day
April 15, 2021
The stock markets are in clover because March retail sales hit 9.8% according to the Department of Commerce.
Via
Talk Markets
Why GlaxoSmithKline Stock Jumped Today
April 15, 2021
An activist investor is reportedly building a significant position in the drugmaker.
Via
The Motley Fool
BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
April 15, 2021
GlaxoSmithKline plc (NYSE: GSK) announced the termination of the Phase II and Phase III studies of feladilimab, its ICOS receptor agonist in head and neck cancer. This comes as a...
Via
Benzinga
GlaxoSmithKline Surges On Report Activist Investor Takes 'Significant' Stake
April 15, 2021
GlaxoSmithKline gained Thursday on a report Elliott Management has built a "significant" stake in the pharmaceutical giant. GSK stock gapped up.
Via
Investor's Business Daily
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Apr. 15, 2021: DELL, AEO, GSK, UNH, INO
April 15, 2021
Today's 5 Stock Ideas: Dell Technologies (DELL) - Shares were up about 8% Thursday morning after the company announced the planned spin-off of VMware. American...
Via
Benzinga
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
April 14, 2021
Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ...
Via
Benzinga
Exposures
COVID-19
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
April 12, 2021
According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) /...
Via
Benzinga
Exposures
COVID-19
Zentalis's Early WEE1 Inhibitor Data Shows 'Exceptional' Response In Solid Tumor Study, Plans Combination Trials
April 12, 2021
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) has announced initial efficacy and safety data from the Phase 1 dose-escalation portion of its ongoing Phase 1/2...
Via
Benzinga
How Important Is Novavax's COVID Vaccine Manufacturing Deal With GlaxoSmithKline?
April 10, 2021
The small biotech is getting critical help from a big pharma company.
Via
The Motley Fool
Exposures
COVID-19
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?
April 10, 2021
One of the three clearly has the most upside potential.
Via
The Motley Fool
Exposures
COVID-19
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
April 08, 2021
The British government and health experts in the country have come forward to defend the COVID-19 vaccine developed by AstraZeneca plc’s (NASDAQ: AZN) and...
Via
Benzinga
Exposures
COVID-19
Weak Markets - Yom HaShoah
April 07, 2021
Today the Biden Administration revealed its planned changes in the corporate tax code.
Via
Talk Markets
Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
April 07, 2021
The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed as a “very rare side effect” of the...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.